(주)이도팜 / IDOPHARM
IDOPHARM's KOBDi Score is 93.66 as of Sep 2026, down 3.37 points since Apr 2025; it rose in 5 and fell in 3 of the 12 monthly updates. As of Sep 2026 it is ahead of about 84% of companies in its industry, against 84% in Aug 2026 and 78% in Apr 2025. Its strongest position was 84% (Sep 2026) and its weakest 78% (Apr 2025).
A year earlier, in Aug 2025, its score was 96.57 and it was ahead of about 80% of companies in its industry.
| Sep 2026 | 93.66 | ahead of 84% |
| Aug 2026 | 93.60 | ahead of 84% |
| Jul 2026 | 92.93 | ahead of 84% |
| Jun 2026 | 92.93 | ahead of 84% |
| May 2026 | 92.93 | ahead of 84% |
| Apr 2026 | 93.38 | ahead of 84% |
| Mar 2026 | 92.72 | ahead of 84% |
| Feb 2026 | 92.70 | ahead of 84% |
| Dec 2025 | 92.09 | ahead of 83% |
| Aug 2025 | 96.57 | ahead of 80% |
| Jul 2025 | 97.03 | ahead of 80% |
| May 2025 | 97.03 | ahead of 79% |
| Apr 2025 | 97.03 | ahead of 78% |
| # | ||||
|---|---|---|---|---|
| 보국(주) BO-KOOK | 1–4 | #75 | ||
| 서울신약 SEOUL VET PHARMA CO.,LTD. | 10–19 | #73 | ||
| (주)한국애보트진단 Abbott Diagnostics Korea Inc. | 500–999 | #72 | ||
| 메디포스트(주) MEDIPOSTCO.,LTD. | 300–499 | #76 | ||
| (주)재세 JAESAE CO.,LTD | 10–19 | #71 | ||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
|
Where is IDOPHARM located?
IDOPHARM is registered at Beonyeon-ro 15beon-gil, Danwon-gu, Ansan-si, Gyeonggi-do, South Korea (postal code 15616).
What industry is IDOPHARM in?
IDOPHARM belongs to Manufacturing › Pharmaceuticals & Biologics › Manufacturing of medical supplies and other medicine-related products.
How many employees does IDOPHARM have?
IDOPHARM has 10–19 employees.
What is IDOPHARM's KOBDi Score?
93.66 as of September 2026, ahead of about 84% of companies in its industry.
Who are IDOPHARM's competitors?
Similar companies include BO-KOOK, SEOUL VET PHARMA and Abbott Diagnostics Korea.


